A2z Radiology AI has secured approval from the US Food and Drug Administration (FDA) for its a2z-Unified-Triage, a multi-condition triage system for abdomen-pelvis CT scans.

The device is designed to simultaneously flag and prioritise seven urgent findings on these CT scans.

It covers seven major acute conditions, including small bowel obstruction, acute pancreatitis, acute cholecystitis, acute diverticulitis, free air, hydronephrosis, and unruptured abdominal aortic aneurysm, in one integration.